Rakhee Vaidya

Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment

National Cancer Institute · R21

PI · $372.8K · Wake Forest University Health Sciences

CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma

Principal investigator · Terminated · Phase 2

Wake Forest University Health Sciences

Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment

Principal investigator · Active not recruiting · Phase 2

Wake Forest University Health Sciences

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Principal investigator · Completed · Phase 1

Wake Forest University Health Sciences

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Site PI · Recruiting · Phase 3

Eastern Cooperative Oncology Group